DKMS and the SBB Research Group Foundation collaborated on a volunteer initiative, part of the Champion A Charity Program, supporting local nonprofits. At Night Shift Brewing near Boston, Massachusetts, a charitable event unfolded as DKMS found a staunch advocate in…
EO Care, a leader in clinically guided cannabinoid-based healthcare treatment, announced today that Milliman, a premier global consulting and actuarial firm, has completed its review of EO Care’s proprietary cost impact model. This model is designed for employers and group…
Zura Bio Limited (NASDAQ: ZURA), a clinical-stage immunology company specializing in novel dual-pathway antibodies for autoimmune and inflammatory diseases, has announced the commencement of an exchange offer (the “Offer”) and consent solicitation (the “Consent Solicitation”) concerning its outstanding IPO warrants.…
Alzamend Neuro, Inc. (Nasdaq: ALZN), a clinical-stage biopharmaceutical company specializing in treatments for Alzheimer’s disease (AD), bipolar disorder (BD), major depressive disorder (MDD), and post-traumatic stress disorder (PTSD), has announced a one-for-ten reverse stock split of its common stock. The…
Harrow (Nasdaq: HROW), a prominent North American eyecare pharmaceutical company, has announced that its management team will attend the 2024 American Society of Retina Specialists (ASRS) Annual Meeting in Stockholm, Sweden, scheduled from July 17-20, 2024. This premier event gathers…
Politan Capital Management, along with its affiliates holding an 8.9% stake in Masimo Corporation (NASDAQ: MASI), has released a statement from Michelle Brennan, an independent director of Masimo: “When I was approached last year about the opportunity to join Masimo’s…
Spotlight Medical, a pioneering startup developing AI-driven prognosis tests to assist physicians in selecting the most effective treatment for cancer patients, has secured €6.2 million in seed funding. The investment round was led by Kurma Partners and Heal Capital. “This…
Oticon Medical announced today that the U.S. Food and Drug Administration (FDA) has approved its Sentio™ System, the company’s first active transcutaneous bone conduction hearing system. Offering enhanced features over the existing Ponto™ System, Sentio System includes the Sentio 1…
Today, Talkspace, a leading online behavioral health care company, has announced a partnership with FlexIt, a top provider of virtual personal wellness services such as personal training, nutrition guidance, and yoga. Together, they will introduce a series of free outdoor…
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that the first patient has been dosed in a Phase 1/2 trial in China, conducted by GenFleet Therapeutics, evaluating GFH375/VS-7375, a KRAS…
A recent survey by Hologic, Inc., reveals that a significant number of American women have postponed or skipped crucial health screenings, despite acknowledging their importance. This national study, conducted by Gallup on behalf of Hologic, underscores a concerning “Screening Action…
Endoron Medical, a pioneering medtech firm specializing in innovative endograft stapling solutions for abdominal aortic aneurysms (AAA), has successfully closed a $10 million Series A funding round. Sofinnova Partners led the round, with substantial contributions from the European Innovation Council…